Role of Transcription Factors in the Pathogenesis of Asthma and COPD

REFERENCES

• Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR (2006). Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med. 273: 1883–1889.
   Google Scholar
• Adair-Kirk TL, Atkinson JJ, Griffin GL, Watson MA, Kelley DG, DeMello D, Senior RM, Betsuyaku T (2008). Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol. 39: 400–411.
   PubMed Web of Science ®Google Scholar
• Adcock IM, Caramori G (2001). Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol. 79: 376–384.
   PubMed Web of Science ®Google Scholar
• Adcock IM, Lane SJ (2003). Corticosteroid-insensitive asthma: Molecular mechanisms. J Endocrinol. 178: 347–355.
   PubMed Web of Science ®Google Scholar
• Adcock IM, Caramori G, Kirkham PA (2012). Strategies for improving the efficacy and therapeutic ratio of glucocorticoids. Curr Opin Pharmacol. 12: 246–251.
   PubMed Web of Science ®Google Scholar
• Allfrey VG, Faulkner R, Mirsky AE (1964). Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA. 51: 786–794.
   PubMed Web of Science ®Google Scholar
• Baldwin AS Jr (2001). Series introduction: The transcription factor NF-kappaB and human disease. J Clin Invest. 107: 3–6.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Chung KF, Page CP (1998). Inflammatory mediators of asthma: an update. Pharmacol Rev. 50: 515–596.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2003). Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med. 167: 813–818.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2004a). Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 56: 515–548.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2004b). Distribution of receptor targets in the lungs. Proc Am Thorac Soc. 1: 345–351.
   PubMedGoogle Scholar
• Barnes PJ, Kleinert S (2004). COPD – a neglected disease. Lancet. 364: 564–565.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2005). Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc. 2: 334–339; discussion 340–341.
   PubMedGoogle Scholar
• Barnes PJ (2006a). Reduced histone deacetylase in COPD: clinical implications. Chest. 129: 151–155.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2006b). Transcription factors in airway diseases. Lab Invest. 86: 867–872.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2008a). Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 8: 183–192.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2008b). The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 118: 3546–3556.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2009). The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 41: 631–638.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2011a). Pathophysiology of allergic inflammation. Immunol Rev. 242: 31–50.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2011b). Biochemical basis of asthma therapy. J Biol Chem. 286: 32899–32905.
   PubMed Web of Science ®Google Scholar
• Barnes PJ (2012a). Development of new drugs for COPD. Curr Med Chem. [Epub ahead of print].
   Web of Science ®Google Scholar
• Barnes PJ (2012b). New drugs for asthma. Semin Respir Crit Care Med. 33: 685–694.
   PubMed Web of Science ®Google Scholar
• Bartlett NW, Slater L, Glanville N, Haas JJ, Caramori G, Casolari P, Clarke DL, Message SD, Aniscenko J, Kebadze T, Zhu J, Mallia P, Mizgerd JP, Belvisi M, Papi A, Kotenko SV, Johnston SL, Edwards MR (2012). Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med. 4: 1244–1260.
   PubMed Web of Science ®Google Scholar
• Beghé B, Hall IP, Parker SG, Moffatt MF, Wardlaw A, Connolly MJ, Fabbri LM, Ruse C, Sayers I (2010). Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy. 65: 474–481.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Zhao Y, Kay TW, Muglia LJ (2011). Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc Natl Acad Sci USA. 108: 9554–9559.
   PubMed Web of Science ®Google Scholar
• Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, Miranda TB, Sung MH, Trump S, Lightman SL, Vinson C, Stamatoyannopoulos JA, Hager GL (2011). Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell. 43: 145–155.
   PubMed Web of Science ®Google Scholar
• Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B, Drouin J (2006). Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 20: 2871–2886.
   PubMed Web of Science ®Google Scholar
• Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, Gabrielson E, Biswal S (2010). Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol. 42: 524–536.
   PubMed Web of Science ®Google Scholar
• Borger P, Matsumoto H, Boustany S, Gencay MM, Burgess JK, King GG, Black JL, Tamm M, Roth M (2007). Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 119: 98–105.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM (2000). Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 161: 1720–1745.
   PubMed Web of Science ®Google Scholar
• Boutten A, Goven D, Artaud-Macari E, Boczkowski J, Bonay M (2011). NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med. 17: 363–371.
   PubMed Web of Science ®Google Scholar
• Broide DH, Lawrence T, Doherty T, Cho JY, Miller M, McElwain K, McElwain S, Karin M (2005). Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium. Proc Natl Acad Sci USA. 102: 17723–17728.
   PubMed Web of Science ®Google Scholar
• Cai LQ, Zhang JY, Yu CX, Zhu L (2012). rhPLD2 suppresses chronic inflammation reactions in a guinea pig asthma model. Immunopharmacol Immunotoxicol. 34: 74–78.
   PubMed Web of Science ®Google Scholar
• Cappello F, Caramori G, Campanella C, Vicari C, Gnemmi I, Zanini A, Spanevello A, Capelli A, La Rocca G, Anzalone R, Bucchieri F, D’Anna SE, Ricciardolo FL, Brun P, Balbi B, Carone M, Zummo G, Conway de Macario E, Macario AJ, Di Stefano A (2011). Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis. PLoS One. 6: e28200.
   PubMed Web of Science ®Google Scholar
• Caramori G, Lim S, Ito K, Tomita K, Oates T, Jazrawi E, Chung KF, Barnes PJ, Adcock IM (2001). Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. Eur Respir J. 18: 466–473.
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock I (2003). Pharmacology of airway inflammation in asthma and COPD. Pulm Pharmacol Ther. 16: 247–277.
   PubMed Web of Science ®Google Scholar
• Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, Chung KF, Barnes PJ, Adcock IM, Ciaccia A, Fabbri LM, Papi A (2003). Nuclear localization of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax. 58: 348–351.
   PubMed Web of Science ®Google Scholar
• Caramori G, Ito K, Adcock IM (2004a). Transcription factors in asthma and COPD. IDrugs. 7: 764–770.
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock IM, Ito K (2004b). Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD. Curr Opin Investig Drugs. 5: 1141–1147.
   PubMedGoogle Scholar
• Caramori G, Pandit A, Papi A (2005). Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? Curr Opin Allergy Clin Immunol. 5: 77–83.
   PubMed Web of Science ®Google Scholar
• Caramori G, Oates T, Nicholson AG, Casolari P, Ito K, Barnes PJ, Papi A, Adcock IM, Chung KF (2009). Activation of NF-kappaB transcription factor in asthma death. Histopathology. 54: 507–509.
   PubMed Web of Science ®Google Scholar
• Caramori G, Casolari P, Giuffrè S, Barczyk A, Adcock I, Papi A (2011). COPD pathology in the small airways. Panminerva Med. 53: 51–70.
   PubMed Web of Science ®Google Scholar
• Chang PJ, Bhavsar PK, Michaeloudes C, Khorasani N, Chung KF (2012). Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma. J Allergy Clin Immunol. 130: 877–885.
   PubMed Web of Science ®Google Scholar
• Chapoval SP, Dasgupta P, Smith EP, DeTolla LJ, Lipsky MM, Kelly-Welch AE, Keegan AD (2011). STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease. J Immunol. 186: 2571–2583.
   Google Scholar
• Chen H, Sun J, Buckley S, Chen C, Warburton D, Wang XF, Shi W (2005). Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol Physiol. 288: L683–691.
   PubMed Web of Science ®Google Scholar
• Chen Lf, Fischle W, Verdin E, Greene WC (2001). Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 293: 1653–1657.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Kim HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, Nakahira K, Pilewski JM, Lee JS, Zhang Y, Ryter SW, Choi AM (2008). Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One. 3: e3316.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Todoroki M, Nishida Y, Tanabe M, Misawa M (2009a). A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. Am J Respir Cell Mol Biol. 41: 516–524.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Todoroki M, Misawa M (2009b). Activation of signal transducer and activator of transcription factor 1 by interleukins-13 and -4 in cultured human bronchial smooth muscle cells. J Smooth Muscle Res. 45: 279–288.
   PubMedGoogle Scholar
• Chiba Y, Todoroki M, Misawa M (2011). Antigen exposure causes activations of signal transducer and activator of transcription 6 (STAT6) and STAT1, but not STAT3, in lungs of sensitized mice. Immunopharmacol Immunotoxicol. 33: 43–48.
   PubMed Web of Science ®Google Scholar
• Cortes JR, Rivas MD, Molina-Infante J, Gonzalez-Nuñez MA, Perez-G M, Masa JF, Sanchez JF, Zamorano J (2009). Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. J Allergy Clin Immunol. 124: 607–610.
   PubMed Web of Science ®Google Scholar
• Cosio BG, Soriano JB (2009). Theophylline again? Reasons for believing. Eur Respir J. 34: 5–6.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F (2011). Th17 cells: new players in asthma pathogenesis. Allergy. 66: 989–998.
   PubMed Web of Science ®Google Scholar
• Darcan-Nicolaisen Y, Meinicke H, Fels G, Hegend O, Haberland A, Kühl A, Loddenkemper C, Witzenrath M, Kube S, Henke W, Hamelmann E (2009). Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice. J Immunol. 182: 7501–7508.
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T, Huntly BJ (2012). Targeting epigenetic readers in cancer. N Engl J Med. 367: 647–657.
   PubMed Web of Science ®Google Scholar
• Demoly P, Basset-Seguin N, Chanez P, Campbell AM, Gauthier-Rouvière C, Godard P, Michel FB, Bousquet J (1992).c-fos proto-oncogene expression in bronchial biopsies of asthmatics. Am J Respir Cell Mol Biol. 7: 128–133.
   PubMed Web of Science ®Google Scholar
• de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003). Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J. 370: 737–749.
   PubMed Web of Science ®Google Scholar
• Diez D, Goto S, Fahy JV, Erle DJ, Woodruff PG, Wheelock ÅM, Wheelock CE (2012). Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics. BMC Med Genomics. 5: 27.
   PubMedGoogle Scholar
• Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, Ioli F, Chung KF, Donner CF, Barnes PJ, Adcock IM (2002). Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J. 20: 556–563.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Capelli A, Gnemmi I, Ricciardolo FL, Oates T, Donner CF, Chung KF, Barnes PJ, Adcock IM (2004). STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J. 24: 78–85.
   PubMed Web of Science ®Google Scholar
• Dubey R, Chhabra R, Saini N (2011). Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines. PLoS One. 6: e28509.
   PubMedGoogle Scholar
• Eriksson U, Egermann U, Bihl MP, Gambazzi F, Tamm M, Holt PG, Bingisser RM (2005). Human bronchial epithelium controls TH2 responses by TH1-induced, nitric oxide-mediated STAT5 dephosphorylation: implications for the pathogenesis of asthma. J Immunol. 175: 2715–2720.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Stephenson ST, Hadley GR, Burwell L, Penugonda M, Simon DM, Hansen J, Jones DP, Brown LA (2011). Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2. J Allergy Clin Immunol. 127: 1604–1611.
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Cutolo M, Genovese MC, Lee EB, Kanik KS, Sadis S, Connell CA, Gruben D, Krishnaswami S, Wallenstein G, Wilkinson BE, Zwillich SH (2012). Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs. Arthritis Rheum. 64: 617–629.
   PubMed Web of Science ®Google Scholar
• Ford PA, Durham AL, Russell RE, Gordon F, Adcock IM, Barnes PJ (2010). Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest. 137: 1338–1344.
   PubMed Web of Science ®Google Scholar
• Fourtounis J, Wang IM, Mathieu MC, Claveau D, Loo T, Jackson AL, Peters MA, Therien AG, Boie Y, Crackower MA (2012). Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11/Eotaxin-1 as a novel NRF2 regulated gene. Respir Res. 13: 92.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R (2009). Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol. 183: 6236–6243.
   PubMed Web of Science ®Google Scholar
• Fulkerson PC, Zimmermann N, Hassman LM, Finkelman FD, Rothenberg ME (2004). Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol. 173: 7565–7574.
   PubMed Web of Science ®Google Scholar
• Fulton DL, Sundararajan S, Badis G, Hughes TR, Wasserman WW, Roach JC, Sladek R (2009). TFCat: the curated catalog of mouse and human transcription factors. Genome Biol. 10: R29.
   PubMedGoogle Scholar
• Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola AM (2003). Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med. 168: 1190–1198.
   PubMed Web of Science ®Google Scholar
• Gagliardo R, Chanez P, Profita M, Bonanno A, Albano GD, Montalbano AM, Pompeo F, Gagliardo C, Merendino AM, Gjomarkaj M (2011). IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 128: 635–645.
   PubMed Web of Science ®Google Scholar
• Galasinski SC, Resing KA, Goodrich JA, Ahn NG (2002). Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem. 277: 19618–19626.
   PubMed Web of Science ®Google Scholar
• Galbán CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galbán S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD (2012). Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 18: 1711–1715.
   PubMed Web of Science ®Google Scholar
• Galliher-Beckley AJ, Williams JG, Cidlowski JA (2011). Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol. 31: 4663–4675.
   PubMed Web of Science ®Google Scholar
• Gao F, Wei D, Bian T, Xie P, Zou J, Mu H, Zhang B, Zhou X (2012). Genistein attenuated allergic airway inflammation by modulating the transcription factors T-bet, GATA-3 and STAT-6 in a murine model of asthma. Pharmacology. 89: 229–236.
   Google Scholar
• Gernez Y, Tirouvanziam R, Nguyen KD, Herzenberg LA, Krensky AM, Nadeau KC (2007). Altered phosphorylated signal transducer and activator of transcription profile of CD4 + CD161 + T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol. 120: 1441–1448.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Warner L, Cascagnette P, Victor JC, To T (2011). Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 378: 991–996.
   PubMed Web of Science ®Google Scholar
• Gilmore TD (2006). Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene. 25: 6680–6684.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report 2002. NHI Publication 02–3659. Last update 2011. http://www.ginasthma.com (accessed January 2012).
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD): global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. NIH Publication No 2701A. Last update 2011. http://www.goldcopd.com/ (accessed 28 May 2012).
   Google Scholar
• Goenka S, Kaplan MH (2011). Transcriptional regulation by STAT6. Immunol Res. 50: 87–96.
   PubMed Web of Science ®Google Scholar
• Goleva E, Kisich KO, Leung DY (2002). A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol. 169: 5934–5940.
   PubMed Web of Science ®Google Scholar
• Goven D, Boutten A, Leçon-Malas V, Marchal-Sommé J, Amara N, Crestani B, Fournier M, Lesèche G, Soler P, Boczkowski J, Bonay M (2008). Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax. 63: 916–924.
   PubMed Web of Science ®Google Scholar
• Grimley PM, Dong F, Rui H (1999). Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10: 131–157.
   PubMed Web of Science ®Google Scholar
• Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, Roberts P, McCann B, Nicholson AG, Harrison BD, Chung KF (2002). Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 40: 367–373.
   PubMed Web of Science ®Google Scholar
• Harada M, Nakashima K, Hirota T, Shimizu M, Doi S, Fujita K, Shirakawa T, Enomoto T, Yoshikawa M, Moriyama H, Matsumoto K, Saito H, Suzuki Y, Nakamura Y, Tamari M (2007). Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am J Respir Cell Mol Biol. 36: 491–496.
   PubMed Web of Science ®Google Scholar
• Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF (1998). Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 158: 1585–1592.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O’Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS Jr (2005). Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol. 116: 550–557.
   PubMed Web of Science ®Google Scholar
• Hawkins GA, Robinson MB, Hastie AT, Li X, Li H, Moore WC, Howard TD, Busse WW, Erzurum SC, Wenzel SE, Peters SP, Meyers DA, Bleecker ER; National Heart, Lung, and Blood Institute–sponsored Severe Asthma Research Program (SARP) (2012). The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol. 130: 510–515.
   Google Scholar
• Hinzey A, Alexander J, Corry J, Adams KM, Claggett AM, Traylor ZP, Davis IC, Webster Marketon JI (2011). Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation. Endocrinology. 152: 483–494.
   PubMed Web of Science ®Google Scholar
• Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L (1998). Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med. 158: 1958–1962.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 350: 2645–2653.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Timens W (2009). The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 4: 435–459.
   PubMed Web of Science ®Google Scholar
• Holgate ST (2011). The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev. 242: 205–219.
   PubMed Web of Science ®Google Scholar
• Homma T, Matsukura S, Hirose T, Ohnishi T, Kimura T, Kurokawa M, Ieki K, Odaka M, Suzuki S, Watanabe S, Sato M, Kawaguchi M, Schleimer RP, Adachi M (2010). Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells. Int Arch Allergy Immunol. 152: 9–17.
   PubMed Web of Science ®Google Scholar
• Huang SL, Su CH, Chang SC (1997). Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 156: 1436–1439.
   PubMed Web of Science ®Google Scholar
• Hudson WH, Youn C, Ortlund EA (2013). The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol. 20: 53–58.
   PubMed Web of Science ®Google Scholar
• Inoue H, Fukuyama S, Matsumoto K, Kubo M, Yoshimura A (2007). Role of endogenous inhibitors of cytokine signaling in allergic asthma. Curr Med Chem. 14: 181–189.
   PubMed Web of Science ®Google Scholar
• Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM (2002). p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol. 109: 649–657.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ, Adcock IM (2000). Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 20: 6891–6903.
   PubMed Web of Science ®Google Scholar
• Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM (2001). Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 15: 1110–1112.
   PubMedGoogle Scholar
• Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ (2002). A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 99: 8921–8926.
   PubMed Web of Science ®Google Scholar
• Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 352: 1967–1976.
   PubMed Web of Science ®Google Scholar
• Ito K, Chung KF, Adcock IM (2006a). Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 117: 522–543.
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM (2006b). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 203: 7–13.
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell. 126: 1121–1133.
   PubMed Web of Science ®Google Scholar
• John AE, Zhu YM, Brightling CE, Pang L, Knox AJ (2009). Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J Immunol. 183: 4682–4692.
   PubMed Web of Science ®Google Scholar
• Kalsheker NA, Morgan K (1994). Regulation of the alpha 1-antitrypsin gene and a disease-associated mutation in a related enhancer sequence. Am J Respir Crit Care Med. 150: S183–S189.
   PubMed Web of Science ®Google Scholar
• Kavalar MS, Balantic M, Silar M, Kosnik M, Korosec P, Rijavec M (2012). Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma. Int J Immunogenet. 39: 20–25.
   PubMed Web of Science ®Google Scholar
• Knosp CA, Carroll HP, Elliott J, Saunders SP, Nel HJ, Amu S, Pratt JC, Spence S, Doran E, Cooke N, Jackson R, Swift J, Fitzgerald DC, Heaney LG, Fallon PG, Kissenpfennig A, Johnston JA (2011). SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med. 208: 1523–1531.
   Google Scholar
• Kobayashi M, Ashino S, Shiohama Y, Wakita D, Kitamura H, Nishimura T (2012). IFN-γ elevates airway hyper-responsiveness via up-regulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model. Eur J Immunol. 42: 393–402.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Mercado N, Barnes PJ, Ito K (2011). Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma. PLoS One. 6: e27627.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Mercado N, Miller-Larsson A, Barnes PJ, Ito K (2012). Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation. Pulm Pharmacol Ther. 25: 201–207.
   PubMed Web of Science ®Google Scholar
• Kouzarides T (2007). Chromatin modifications and their function. Cell. 128: 693–705.
   PubMed Web of Science ®Google Scholar
• Kuperman DA, Schleimer RP (2008). Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med. 8: 384–392.
   PubMed Web of Science ®Google Scholar
• Lane SJ, Adcock IM, Richards D, Hawrylowicz C, Barnes PJ, Lee TH (1998). Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest. 102: 2156–2164.
   PubMed Web of Science ®Google Scholar
• Langlais D, Couture C, Balsalobre A, Drouin J (2012). The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol Cell. 47: 38–49.
   Google Scholar
• Lau A, Tian W, Whitman SA, Zhang DD (2013). The predicted molecular weight of nrf2: it is what it is not. Antioxid Redox Signal. 18: 91–93.
   PubMed Web of Science ®Google Scholar
• Li B, Carey M, Workman JL (2007). The Role of Chromatin during Transcription. Cell. 128: 707–719.
   PubMed Web of Science ®Google Scholar
• Li G, Liu Z, Ran P, Qiu J, Zhong N (2004). Activation of signal transducer and activator of transcription 5 (STAT5) in splenocyte proliferation of asthma mice induced by ovalbumin. Cell Mol Immunol. 1: 471–474.
   PubMed Web of Science ®Google Scholar
• Lim S, Crawley E, Woo P, Barnes PJ (1998). Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 352: 113.
   PubMed Web of Science ®Google Scholar
• Lim S, Caramori G, Tomita K, Jazrawi E, Oates T, Chung KF, Barnes PJ, Adcock IM (2004). Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. Allergy. 59: 505–514.
   PubMed Web of Science ®Google Scholar
• Liu YS, Tsai PW, Wang Y, Fan TC, Hsieh CH, Chang MD, Pai TW, Huang CF, Lan CY, Chang HT (2012). Chemoattraction of macrophages by secretory molecules derived from cells expressing the signal peptide of eosinophil cationic protein. BMC Syst Biol. 6: 105.
   PubMedGoogle Scholar
• Loke TK, Mallett KH, Ratoff J, O’Connor BJ, Ying S, Meng Q, Soh C, Lee TH, Corrigan CJ (2006). Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J Allergy Clin Immunol. 118: 368–375.
   PubMed Web of Science ®Google Scholar
• Luecke HF, Yamamoto KR (2005). The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 19: 1116–1127.
   PubMed Web of Science ®Google Scholar
• Lührmann A, Tschernig T, von der Leyen H, Hecker M, Pabst R, Wagner AH (2010). Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model. Exp Lung Res. 36: 85–93.
   PubMed Web of Science ®Google Scholar
• McCusker CT, Wang Y, Shan J, Kinyanjui MW, Villeneuve A, Michael H, Fixman ED (2007). Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J Immunol. 179: 2556–2564.
   PubMed Web of Science ®Google Scholar
• Maddur MS, Miossec P, Kaveri SV, Bayry J (2012). Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 181: 8–18.
   PubMed Web of Science ®Google Scholar
• Maher B (2012). ENCODE: The human encyclopaedia. Nature. 489: 46–48.
   PubMed Web of Science ®Google Scholar
• Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A, Chen L, Zhuang X, Hogg J, Pare P, Tuder RM, Biswal S (2008). Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med. 178: 592–604.
   PubMed Web of Science ®Google Scholar
• Malhotra D, Thimmulappa RK, Mercado N, Ito K, Kombairaju P, Kumar S, Ma J, Feller-Kopman D, Wise R, Barnes P, Biswal S (2011). Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest. 121: 4289–4302.
   PubMed Web of Science ®Google Scholar
• Manning AM, Davis RJ (2003). Targeting JNK for therapeutic benefit: From junk to gold? Nat Rev Drug Discov. 2: 554–565.
   PubMed Web of Science ®Google Scholar
• Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA (2007). Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature. 445: 931–935.
   PubMed Web of Science ®Google Scholar
• Martinez-Nunez RT, Louafi F, Sanchez-Elsner T (2011). The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 286: 1786–1794.
   PubMed Web of Science ®Google Scholar
• Marwick JA, Wallis G, Meja K, Kuster B, Bouwmeester T, Chakravarty P, Fletcher D, Whittaker PA, Barnes PJ, Ito K, Adcock IM, Kirkham PA (2008). Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 377: 797–802.
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Stevenson CS, Casolari P, Jazrawi E, Barnes PJ, Ito K, Adcock IM, Kirkham PA, Papi A (2009). Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med. 179: 542–548.
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Casolari P, Mazzoni F, Kirkham PA, Adcock IM, Chung KF, Papi A (2010). A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 125: 1146–1153.
   PubMed Web of Science ®Google Scholar
• Matsunaga Y, Inoue H, Fukuyama S, Yoshida H, Moriwaki A, Matsumoto T, Matsumoto K, Asai Y, Kubo M, Yoshimura A, Nakanishi Y (2011). Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma. Biochem Biophys Res Commun. 404: 261–267.
   Google Scholar
• Matthews JG, Ito K, Barnes PJ, Adcock IM (2004). Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol. 113: 1100–1108.
   PubMed Web of Science ®Google Scholar
• Michaeloudes C, Chang PJ, Petrou M, Chung KF (2011). Transforming growth factor-β and nuclear factor E2–related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. Am J Respir Crit Care Med. 184: 894–903.
   PubMed Web of Science ®Google Scholar
• Morgan K, Scobie G, Marsters P, Kalsheker NA (1997). Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. Biochim Biophys Acta. 1362: 67–76.
   PubMed Web of Science ®Google Scholar
• Morjaria JB, Babu KS, Vijayanand P, Chauhan AJ, Davies DE, Holgate ST (2011). Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. Thorax. 66: 537.
   PubMed Web of Science ®Google Scholar
• Mullings RE, Wilson SJ, Puddicombe SM, Lordan JL, Bucchieri F, Djukanović R, Howarth PH, Harper S, Holgate ST, Davies DE (2001). Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol. 108: 832–838.
   PubMed Web of Science ®Google Scholar
• Nagashima S, Nagata H, Iwata M, Yokota M, Moritomo H, Orita M, Kuromitsu S, Koakutsu A, Ohga K, Takeuchi M, Ohta M, Tsukamoto S (2008). Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors. Bioorg Med Chem. 16: 6509–6521.
   PubMed Web of Science ®Google Scholar
• Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, Yuyama N, Yamaya M, Nakayama K, Kubo H, Watanabe M, Sagara H, Sugiyama K, Tanaka H, Toda S, Hayashi H, Inoue H, Hoshino T, Shiraki A, Inoue M, Suzuki K, Aizawa H, Okinami S, Nagai H, Hasegawa M, Fukuda T, Green ED, Izuhara K (2008). Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol. 180: 6262–6269.
   PubMed Web of Science ®Google Scholar
• Nath P, Eynott P, Leung SY, Adcock IM, Bennett BL, Chung KF (2005). Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur J Pharmacol. 506: 273–283.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Finotto S, Glimcher LH (2002). The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 8: 567–573.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Finotto S (2011). IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 22: 83–89.
   PubMed Web of Science ®Google Scholar
• Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM (2004). Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA. 101: 14895–14900.
   PubMed Web of Science ®Google Scholar
• Ning W, Dong Y, Sun J, Li C, Matthay MA, Feghali-Bostwick CA, Choi AM (2007). Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung Fibroblasts. Am J Respir Cell Mol Biol. 36: 480–490.
   PubMed Web of Science ®Google Scholar
• Nofziger C, Vezzoli V, Dossena S, Schönherr T, Studnicka J, Nofziger J, Vanoni S, Stephan S, Silva ME, Meyer G, Paulmichl M (2011). STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease. Clin Pharmacol Ther. 90: 399–405.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK (2005). Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 122: 707–721.
   PubMed Web of Science ®Google Scholar
• Oh CK, Geba GP, Molfino N (2010). Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev. 19: 46–54.
   PubMedGoogle Scholar
• O’Shea JJ, Plenge R (2012). JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 36: 542–550.
   PubMed Web of Science ®Google Scholar
• Ouaked N, Mantel PY, Bassin C, Burgler S, Siegmund K, Akdis CA, Schmidt-Weber CB (2009). Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol. 182: 1041–1049.
   PubMed Web of Science ®Google Scholar
• Pan H, Cao J, Xu W (2012). Selective histone deacetylase inhibitors. Anticancer Agents Med Chem. 12: 247–270.
   PubMed Web of Science ®Google Scholar
• Papi A, Johnston SL (1999). Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem. 274: 9707–9720.
   PubMed Web of Science ®Google Scholar
• Perkins ND (2006). Post-translational modifications regulating the activity and function of the nuclear factor kappaB pathway. Oncogene. 25: 6717–6730.
   PubMed Web of Science ®Google Scholar
• Perkins ND (2012). The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer. 12: 121–132.
   PubMed Web of Science ®Google Scholar
• Poynter ME, Irvin CG, Janssen-Heininger YM (2002). Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol. 160: 1325–1334.
   PubMed Web of Science ®Google Scholar
• Profita M, Sala A, Bonanno A, Siena L, Ferraro M, Di Giorgi R, Montalbano AM, Albano GD, Gagliardo R, Gjomarkaj M (2008). Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. J Pharmacol Exp Ther. 325: 1024–1030.
   PubMed Web of Science ®Google Scholar
• Pullen NA, Barnstein BO, Falanga YT, Wang Z, Suzuki R, Tamang TD, Khurana MC, Harry EA, Draber P, Bunting KD, Mizuno K, Wilson BS, Ryan JJ (2012). Novel mechanism for Fc{epsilon}RI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production. J Biol Chem. 287: 2045–2054.
   PubMed Web of Science ®Google Scholar
• Quarcoo D, Weixler S, Groneberg D, Joachim R, Ahrens B, Wagner AH, Hecker M, Hamelmann E (2004). Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J Allergy Clin Immunol. 114: 288–295.
   PubMed Web of Science ®Google Scholar
• Rahman I (2005). Redox signaling in the lungs. Antioxid Redox Signal. 7: 1–5.
   PubMed Web of Science ®Google Scholar
• Rahman I, MacNee W (2012). Antioxidant pharmacological therapies for COPD. Curr Opin Pharmacol. 12: 256–265.
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I (2008). SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 177: 861–870.
   PubMed Web of Science ®Google Scholar
• Ram FS, Jones PW, Castro AA, De Brito JA, Atallah AN, Lacasse Y, Mazzini R, Goldstein R, Cendon S (2002). Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 4: CD003902.
   PubMedGoogle Scholar
• Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 114: 1248–1259.
   PubMed Web of Science ®Google Scholar
• Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, Biswal S (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 202: 47–59.
   PubMed Web of Science ®Google Scholar
• Ray A, Khare A, Krishnamoorthy N, Qi Z, Ray P (2010). Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3: 216–229.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J; COPD Investigators (2007). The Safety and Efficacy of Infliximab in Moderate-To-Severe Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 156: 926–934.
   Google Scholar
• Rincon M, Irvin CG (2012). Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 8: 1281–1290.
   PubMed Web of Science ®Google Scholar
• Romagnani S (2006). Regulation of the T cell response. Clin Exp Allergy. 36: 1357–1366.
   PubMed Web of Science ®Google Scholar
• Roth M, Johnson PR, Rüdiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL (2002). Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet. 360: 1293–1299.
   PubMed Web of Science ®Google Scholar
• Roth M, Johnson PR, Borger P, Bihl MP, Rüdiger JJ, King GG, Ge Q, Hostettler K, Burgess JK, Black JL, Tamm M (2004). Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med. 351: 560–574.
   PubMed Web of Science ®Google Scholar
• Saklatvala J (2004). The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol. 4: 372–377.
   PubMed Web of Science ®Google Scholar
• Sampath D, Castro M, Look DC, Holtzman MJ (1999). Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J Clin Invest. 103: 1353–1361.
   Google Scholar
• Sandborn WJ, Ghosh S, Panes J, Vranic I, Su C, Rousell S, Niezychowski W; Study A3921063 Investigators (2012). Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med. 367: 616–624.
   Google Scholar
• Sandford AJ, Malhotra D, Boezen HM, Siedlinski M, Postma DS, Wong V, Akhabir L, He JQ, Connett JE, Anthonisen NR, Paré PD, Biswal S (2012). NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease. Physiol Genomics. 44: 754–763.
   PubMed Web of Science ®Google Scholar
• Sareila O, Hämäläinen M, Nissinen E, Kankaanranta H, Moilanen E (2008). Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli. J Pharmacol Exp Ther. 324: 858–866.
   PubMed Web of Science ®Google Scholar
• Schneider D, Ganesan S, Comstock AT, Meldrum CA, Mahidhara R, Goldsmith AM, Curtis JL, Martinez FJ, Hershenson MB, Sajjan U (2010). Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182: 332–340.
   PubMed Web of Science ®Google Scholar
• Shelburne CP, McCoy ME, Piekorz R, Sexl V, Roh KH, Jacobs-Helber SM, Gillespie SR, Bailey DP, Mirmonsef P, Mann MN, Kashyap M, Wright HV, Chong HJ, Bouton LA, Barnstein B, Ramirez CD, Bunting KD, Sawyer S, Lantz CS, Ryan JJ (2003). Stat5 expression is critical for mast cell development and survival. Blood. 102: 1290–1297.
   Google Scholar
• Silverpil E, Lindén A (2012). IL-17 in human asthma. Expert Rev Respir Med. 6: 173–186.
   PubMed Web of Science ®Google Scholar
• Sousa AR, Lane SJ, Soh C, Lee TH (1999). In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. J Allergy Clin Immunol. 104: 565–574.
   PubMed Web of Science ®Google Scholar
• Strengell M, Matikainen S, Sirén J, Lehtonen A, Foster D, Julkunen I, Sareneva T (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol. 170: 5464–5469.
   PubMed Web of Science ®Google Scholar
• Strickland DH, Holt PG (2011). T regulatory cells in childhood asthma. Trends Immunol. 32: 420–427.
   PubMed Web of Science ®Google Scholar
• Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, Li M, Chambon P (2011). Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell. 145: 224–241.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, Kondo S, Nishimura M (2008). Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 39: 673–682.
   PubMed Web of Science ®Google Scholar
• Szulakowski P, Crowther AJ, Jimenez LA, Donaldson K, Mayer R, Leonard TB, MacNee W, Drost EM (2006). The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 174: 41–50.
   PubMed Web of Science ®Google Scholar
• Tian XR, Tian XL, Bo JP, Li SG, Liu ZL, Niu B (2011). Inhibition of allergic airway inflammation by antisense-induced blockade of STAT6 expression. Chin Med J (Engl). 124: 26–31.
   PubMed Web of Science ®Google Scholar
• To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM, Barnes PJ (2010). Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182: 897–904.
   PubMed Web of Science ®Google Scholar
• Tomita K, Caramori G, Ito K, Sano H, Lim S, Oates T, Cosio B, Chung KF, Tohda Y, Barnes PJ, Adcock IM (2012). STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects. J Inflamm (Lond). 9: 5.
   Google Scholar
• Tomkinson A, Kanehiro A, Rabinovitch N, Joetham A, Cieslewicz G, Gelfand EW (1999). The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am J Respir Crit Care Med. 160: 1283–1291.
   Google Scholar
• Tsitoura DC, Rothman PB (2004). Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4 + T cells. J Clin Invest. 113: 619–627.
   PubMed Web of Science ®Google Scholar
• Turlej RK, Fiévez L, Sandersen CF, Dogné S, Kirschvink N, Lekeux P, Bureau F (2001). Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax. 56: 696–702.
   PubMed Web of Science ®Google Scholar
• Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, Schwalie P, Hübner N, Evans RM (2013). Insights into Negative Regulation by the Glucocorticoid Receptor from Genome-wide Profiling of Inflammatory Cistromes. Mol Cell. 49: 158–171.
   PubMed Web of Science ®Google Scholar
• Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, O’Shea JJ (2012). STATs shape the active enhancer landscape of T cell populations. Cell. 151: 981–993.
   PubMed Web of Science ®Google Scholar
• van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B; ORAL Standard Investigators (2012). Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N Engl J Med. 367: 508–519.
   Google Scholar
• Wang IM, Lin H, Goldman SJ, Kobayashi M (2004). STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Mol Immunol. 41: 873–884.
   PubMed Web of Science ®Google Scholar
• Wang W, Hansbro PM, Foster PS, Yang M (2011). An alternate STAT6-independent pathway promotes eosinophil influx into blood during allergic airway inflammation. PLoS One. 6: e17766.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Shan J, Fixman E, McCusker C (2011). Effective treatment of experimental ragweed-induced asthma with STAT-6-IP, a topically delivered cell-penetrating peptide. Clin Exp Allergy. 41: 1622–1630.
   PubMed Web of Science ®Google Scholar
• Wohlmann A, Sebastian K, Borowski A, Krause S, Friedrich K (2010). Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function. Biol Chem. 391: 181–186.
   PubMed Web of Science ®Google Scholar
• Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A (2006). FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 126: 375–387.
   PubMed Web of Science ®Google Scholar
• Yan J, Xiang J, Lin Y, Ma J, Zhang J, Zhang H, Sun J, Danial NN, Liu J, Lin A (2013). Inactivation of BAD by IKK Inhibits TNFα-Induced Apoptosis Independently of NF-κB Activation. Cell. 152: 304–315.
   PubMed Web of Science ®Google Scholar
• Yang IV, Tomfohr J, Singh J, Foss CM, Marshall HE, Que LG, McElvania-Tekippe E, Florence S, Sundy JS, Schwartz DA (2012). The clinical and environmental determinants of airway transcriptional profiles in allergic asthma. Am J Respir Crit Care Med. 185: 620–627.
   PubMed Web of Science ®Google Scholar
• Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O’Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW (2012). The transcription factor encyclopedia. Genome Biol. 13: R24.
   PubMed Web of Science ®Google Scholar
• Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, van der Geld YM, Timens W (2006). Altered expression of the Smad signalling pathway: Implications for COPD pathogenesis. Eur Respir J. 28: 533–541.
   PubMed Web of Science ®Google Scholar
• Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, Timens W (2008). Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD. Respir Res. 9: 83.
   PubMedGoogle Scholar
• Zhang N, Truong-Tran QA, Tancowny B, Harris KE, Schleimer RP (2007). Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J Immunol. 179: 578–589.
   PubMed Web of Science ®Google Scholar
• Zhang S, Lukacs NW, Lawless VA, Kunkel SL, Kaplan MH (2000). Cutting edge: Differential expression of chemokines in Th1 and Th2 cells is dependent on STAT6 but not STAT4. J Immunol. 165: 10–14.
   PubMed Web of Science ®Google Scholar
• Zhang W, Prakash C, Sum C, Gong Y, Li Y, Kwok JJ, Thiessen N, Pettersson S, Jones SJ, Knapp S, Yang H, Chin KC (2012). Bromodomain-containing Protein 4 (BRD4) Regulates RNA Polymerase II Serine 2 Phosphorylation in Human CD4 + T Cells. J Biol Chem. 287: 43137–43155.
   PubMed Web of Science ®Google Scholar
• Zheng W, Flavell RA (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89: 587–596.
   PubMed Web of Science ®Google Scholar
• Zhong H, May MJ, Jimi E, Ghosh S (2002). The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol Cell. 9: 625–636.
   PubMed Web of Science ®Google Scholar
• Zhou L, Kawate T, Liu X, Kim YB, Zhao Y, Feng G, Banerji J, Nash H, Whitehurst C, Jindal S, Siddiqui A, Seed B, Wolfe JL (2012). STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells. Bioorg Med Chem. 20: 750–758.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE (2006). GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 16: 3–10.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Chen L, Huang Z, Alkan S, Bunting KD, Wen R,Wang D, Huang H (2004). Cutting edge: IL-5 primes Th2 cytokine-producing capacity in eosinophils through a STAT5-dependent mechanism. J Immunol. 173: 2918–2922.
   Google Scholar